AC |
Human osteoblasts |
0.2 V, 1.4 V, or 2.8 V were applied to the in vitro system with 20 Hz frequency |
0.2 V, 1.4 V increased bone regeneration while 2.8V decreased |
[107] |
CC |
Human osteoblasts |
100 mVrms electrical stimulation |
Increase in metabolic activity and expression of bone remodeling markers with reduced procollagen type 1 synthesis |
[108] |
DC |
MC3T3 |
0 (control), 125, 250 and 500 mV/mm |
An increase in proliferation |
[109] |
AC |
Rat |
A square pulse at a frequency of 10 Hz and a rest-insertion period of 1-s contraction followed by 4-s rest, with two different intensities of 8 or 16 mA. |
Did not affect the healing process |
[110] |
DC |
hBMSCs |
2.2 V |
Enhanced expression of OPN and no effect on RUNX2. Decreased ALP activity in stimulated samples. |
[111] |
DC |
Rat |
0.1–0.2 μA |
Increased neovascular and endochondral bone formation |
[112] |
DC |
Beagle dogs |
10 μA and 20 μA |
Significant increase in BIC after 15 days of stimulation of 20 μA compared to stimulation of 10 μA and control group. No significant results between groups after 7 days |
[113] |
PMEF |
Rat |
3850 Hz pulse frequency and 15 Hz repetition rate at 10 T/s (T/s), 30 T/s, 100 T/s, or 300 T/s |
30 T/s PEMF treatment approached the efficacy of alendronate in reducing trabecular bone loss, but differed from it by not reducing bone formation rates. |
[114] |